![](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1576849703/news-1172463_1920.jpg/news-1172463_1920.jpg?VersionId=mgpnHbk7Co5__dvZ_o.s5E2ae_oUpz54)
Regulatory tracker: Novo Nordisk's Wegovy approved to cut cardiovascular risks in the UK
Welcome to Fierce Pharma's regulatory tracker for the second half of 2024. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. UPDATED: Tuesday, July 23 at 5:35 …